Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Meridian Bioscience Inc. (VIVO)
NASDAQ:VIVO
Meridian Bioscience (VIVO) Financial Statements
0 Followers
Meridian Bioscience Financial Overview
| Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 65.67M | $ 67.77M | $ 111.23M | $ 88.34M | $ 76.20M |
| Gross Profit | $ 33.99M | $ 36.73M | $ 68.48M | $ 49.16M | $ 44.72M |
| EBIT | $ 4.85M | $ -6.35M | $ 36.88M | $ 20.12M | $ 8.28M |
| EBITDA | $ 8.92M | $ -2.24M | $ 41.03M | $ 24.31M | $ 12.39M |
| Net Income Common Stockholders | $ 5.71M | $ -7.34M | $ 28.75M | $ 15.34M | $ 6.66M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 81.45M | $ 83.49M | $ 76.49M | $ 72.73M | $ 49.77M |
| Total Assets | $ 463.10M | $ 465.93M | $ 471.81M | $ 458.64M | $ 449.72M |
| Total Debt | $ 30.96M | $ 31.80M | $ 32.71M | $ 55.59M | $ 65.92M |
| Net Debt | $ -50.50M | $ -51.69M | $ -43.77M | $ -17.14M | $ 16.15M |
| Total Liabilities | $ 95.04M | $ 100.38M | $ 97.18M | $ 113.42M | $ 121.42M |
| Stockholders Equity | $ 368.06M | $ 365.55M | $ 374.63M | $ 345.22M | $ 328.30M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -1.49M | $ 12.44M | $ 28.95M | $ 33.85M | $ 12.57M |
| Operating Cash Flow | $ 1.99M | $ 14.40M | $ 30.42M | $ 35.55M | $ 14.48M |
| Investing Cash Flow | $ -2.23M | $ -5.71M | $ -1.47M | $ -1.71M | $ -18.99M |
| Financing Cash Flow | $ -472.00K | $ 1.64M | $ -24.38M | $ -11.09M | $ -15.18M |
Meridian Bioscience Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.